Intrahepatic hepatitis C virus-specific cytotoxic T lymphocyte activity and response to interferon alfa therapy in chronic hepatitis C. (Q42988942)

12 November 2017

Intrahepatic hepatitis C virus-specific cytotoxic T lymphocyte activity and response to interferon alfa therapy in chronic hepatitis C. (English)

1 reference

12 November 2017

0 references

1 reference

1 reference

1 reference

1 reference

Nelson DR

1

1 reference

12 November 2017

Marousis CG

2

1 reference

12 November 2017

Ohno T

3

1 reference

12 November 2017

Davis GL

4

1 reference

12 November 2017

Lau JY

5

1 reference

12 November 2017

language of work or name

English

0 references

publication date

1 July 1998

1 reference

12 November 2017

1 reference

12 November 2017

28

1 reference

12 November 2017

1

1 reference

12 November 2017

225-230

1 reference

Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response

12 November 2017

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280129

7 January 2021

Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280129

7 January 2021

Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280129

7 January 2021

Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280129

7 January 2021

Prediction of response to interferon treatment of chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280129

7 January 2021

Factors affecting treatment responses to interferon-alpha in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280129

7 January 2021

Clinical predictors of response to recombinant interferon-alpha treatment in patients with chronic non-A, non-B hepatitis (hepatitis C). The Hepatitis Interventional Therapy Group

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280129

7 January 2021

Hepatic iron concentration as a predictor of response to interferon alfa therapy in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280129

7 January 2021

Implications of variations of "conserved" regions of hepatitis C virus genome

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280129

7 January 2021

Survey of major genotypes and subtypes of hepatitis C virus using RFLP of sequences amplified from the 5' non-coding region

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280129

7 January 2021

Distribution of hepatitis C virus genotypes determined by line probe assay in patients with chronic hepatitis C seen at tertiary referral centers in the United States. Hepatitis Interventional Therapy Group

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280129

7 January 2021

A proposed system for the nomenclature of hepatitis C viral genotypes

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280129

7 January 2021

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280129

7 January 2021

Hepatic HLA antigen display in chronic hepatitis B virus infection. Relation to hepatic expression of HBV genome/gene products and liver histology

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280129

7 January 2021

Cytotoxic T lymphocyte response and viral load in hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280129

7 January 2021

Differential cytotoxic T-lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280129

7 January 2021

A helper T-cell antigen enhances generation of hepatitis C virus-specific cytotoxic T lymphocytes in vitro

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280129

7 January 2021

Collaboration of helper and cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280129

7 January 2021

Effects of interferon treatment on the antiviral T-cell response in hepatitis C virus genotype 1b- and genotype 2c-infected patients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280129

7 January 2021

Persistent hepatitis C virus infection in a chimpanzee is associated with emergence of a cytotoxic T lymphocyte escape variant

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280129

7 January 2021

Identifiers

DOI

10.1002/HEP.510280129

1 reference

12 November 2017

1 reference